Finanzas de Prokidney Corp (PROK)PROKProkidney Corp

Evaluating the bottom line, Prokidney Corp maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -32248.67%, while the net margin is -30957.33%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively PROK converts its operational activities into shareholder value.

In the context of the broader market, PROK competes directly with industry leaders such as AGMB and DMAC. With a market capitalization of $421.74M, it holds a significant position in the sector. When comparing efficiency, PROK's gross margin of 100.00% stands against AGMB's N/A and DMAC's N/A. Such benchmarking helps identify whether Prokidney Corp is trading at a premium or discount relative to its financial performance.

ProKidney has shown a concerning trend in its financials, with a net income loss of -$28.42 million in Q2 2026 and a year-to-date change of -40.36%. Despite a gross margin of 100%, the company is struggling with high operational costs, leading to a negative net margin of -30,957.33%.